Evidence map›Paper›PMID 33925766›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Prediction of Hypertension Outcomes Based on Gain Sequence Forward Tabu Search Feature Selection and XGBoost.

Wenbing Chang, Xinpeng Ji, Yiyong Xiao, Yue Zhang, Bang Chen, Houxiang Liu, Shenghan Zhou

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Predicting Early-Onset Colorectal Cancer with Large Language Models.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenbing ChangSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.
Xinpeng JiSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.ORCID 0000-0003-0871-9362
Yiyong XiaoSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.ORCID 0000-0001-5879-8906
Yue ZhangSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.
Bang ChenSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.ORCID 0000-0003-2182-2807
Houxiang LiuSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.ORCID 0000-0002-0503-9161
Shenghan ZhouSchool of Reliability and Systems Engineering, Beihang University, Beijing 100191, China.ORCID 0000-0001-7979-4912

Funding

Fundamental Research Funds for the Central Universities YWF-20-BJ-J-943Graduate Student Education & Development Foundation of Beihang University noneNational Natural Science Foundation of China 71971013 & 71871003 & 71501007
6 · The paper itself

Abstract

For patients with hypertension, serious complications, such as myocardial infarction, a common cause of heart failure, occurs in the late stage of hypertension. Hypertension outcomes can lead to complications, including death. Hypertension outcomes threaten patients' lives and need to be predicted. In our research, we reviewed the hypertension medical data from a tertiary-grade A class hospital in Beijing, and established a hypertension outcome prediction model with the machine learning theory. We first proposed a gain sequence forward tabu search feature selection (GSFTS-FS) method, which can search the optimal combination of medical variables that affect hypertension outcomes. Based on this, the XGBoost algorithm established a prediction model because of its good stability. We verified the proposed method by comparing other commonly used models in similar works. The proposed GSFTS-FS improved the performance by about 10%. The proposed prediction method has the best performance and its AUC value, accuracy, F1 value, and recall of 10-fold cross-validation were 0.96. 0.95, 0.88, and 0.82, respectively. It also performed well on test datasets with 0.92, 0.94, 0.87, and 0.80 for AUC, accuracy, F1, and recall, respectively. Therefore, the XGBoost with GSFTS-FS can accurately and effectively predict the occurrence of outcomes for patients with hypertension, and can provide guidance for doctors in clinical diagnoses and medical decision-making.

Indexed as

biomedical engineeringdisease predictionfeature selectiongain sequence forward tabu searchhypertension outcomesXGBoost

Identifiers

PMID33925766
PMCPMC8146551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.